Semen specimens from four groups of patients were evaluated for coagulation and fibrinolysis factors: a group of patients with infertile semen and involuntary childlessness (n = 35), a group with fertile semen and involuntary childlessness (n = 39), a group with fertile semen and proven fertility before vasectomy (n = 34) and a group with infertile semen after vasectomy (n = 147).
Introduction
, A _, T , , A , --, ( 4, 5) . It has been suggested that the degree of coagImmediately after ejaculation, semen is coagulated ulation of ejaculated semen may be correlated with and liquefaction takes 5 to 20 minutes (1) . The clotting epididymal function (3) and that subfertility may be process is induced by the enzyme vasiculase original·· associated with poor coagulation caused by a lower ing from the prostate gland. The coagulum consists osmolality and buffering capacity and a higher pH of a fibrin-like material, which is considered to be than samples showing good coagulation (6) . The aim composed of sialo-glycoprotein-metal complexes (2) of the study was to assess if the fibrin-like coagulum and of glycerylphosphorylcholine (3) . The high mo-contained (or had contained) fibrin by measuring lecular weight seminal vesicle protein is degraded by coagulation activation and fibrinolysis products in the proteases of the prostatic fluid when the clot liquefies seminal plasma after liquefaction, and to establish reference ranges in normal seminal plasmas. Finally the measured quantities were compared in involuntarily childless and normal males. The relevant part of the coagulation and fibrinolysis cascade is given in figure 1.
Materials and Methods

Methods
Fibrinogen was measured with a clotting assay (Merz and Dade) according to the method of Clauss, by means of a Schnitger and Gross coagulometer. Factor VIIIic was determined in a one stage clotting assay with the aid of a F VIII deficient plasma of Behring (Marburg, Germany). Antithrombin III was assessed with a chromogenic substrate method of the Behring Corporation (Germany). The chromogenic Coa set FM test of Kabi Vitrum Diagnostica (M lndal, Sweden) was used for the fibrin monomer determinations. The thrombinantithrombin III was determined using an ELISA test kit from Behring (Behring Marburg, Germany). The fibrin degradation products were measured by means of the D-dimer test (Boehringer Mannheim, Mannheim, Germany). The D-dimer test is a specific ELISA test for the determination of degradation products of cross-linked fibrin only and not of fibrinogen. Plasminogen activator inhibitor-1 and tissue plasminogen activator activity were quantitated by measuring the enzymatic activity of the plasmin generated in the test procedure in the presence of fibrinogen fragments against the synthetic substrate S-2251 (Kabi Vitrum Diagnostica).
Precision of the methods
For thrombin-antithrombin III the intra-assay and inter-assay coefficient of variation were 5.1% and 7.4% respectively. The D-dimer analysis showed a intra-assay coefficient of variation of 7.1% and an inter-assay coefficient of variation of 10.0%. The coefficients of variation obtained for the tissue plasminogen activator activity assay were 6.2% for the intra-assay variation and 10.1% for the inter-assay variation.
Samples
The semen was obtained at home after masturbation and was collected in graduated tubes. The material had to be presented in the laboratory whithin one hour of production. The semen was centrifuged after liquefaction (2000 g at room temperature, 10 min) and the seminal plasma collected. The supernatant was deep frozen at -70 °C until the next batch of measurements.
Patients
Quantities associated with coagulation and fibrinolysis were investigated in the seminal plasma of 255 patients. The patients under evaluation for infertility were subdivided into two groups: group I (n = 35) consisted of men with infertile semen according to the sperm concentration and motility and group II (n = 39) of men with fertile semen according to the sperm concentration and motility, but without proven fertility. It is considered to be normal if the sperm concentration is > 20 χ 10 9 /1 and the progressive motility is > 30% (7). The seminal plasma for male individuals with proven fertility, who came to the urology clinic for vasectomy (group III, n = 34), was used as a positive control group; the seminal plasma of a group of vasectomized patients (group IV, n = 147) was used as a negative control group. All the patients underwent urological examination for the exclusion of anatomical, infectious and endocrinological abnormalities. In the group of males attending the clinic for assessment because of a marriage with delayed fertility, female infertility factors were excluded. The Mann-Whitney-Wilcoxon test was employed for the comparison of the patient groups with each other and of the patient groups with the reference group.
Results
As can be seen in table 1, measurable quantities of fibrinogen, plasminogen, plasminogen activator inhibitor-1, factor VIH:c and fibrin monomers could not be detected, and the antithrombin III level was low (0.2-0.6%).
In table 2 the reference ranges for the relevant quantities in blood plasma are given. rombin III ratio (p = 0.02). There were no significant differences between the vasectomized patients and group III, nor could any significant difference be found between groups I and IV or II and IV. Significant differences were found for the D-dimer levels and D-dimer/thrombin-antithrombin III ratios between the postvasectomy group IV and the prevasectomy patient group III (p-values 0.026 and 0.0008, respectively).
Discussion
The presence of the coagulation and fibrinolysis markers thrombin-antithrombin III and D-dimer, together with the extremely high tissue plasminogen activator levels (in comparison with the blood plasma concentrations), is an indication that they have a function in semen and that the seminal coagulum is at least partly composed of fibrin. It seems that the low antithrombin III concentration (600-1800 μg/l) is high enough for the thrombin-antithrombin III complex formation in the concentrations measured in this study. We could not measure directly the presence of prothrombin but in the meantime we found considerable amounts of prothrombin fragment 1.2 in the seminal plasma (still unpublished data). This is indirect evidence for the presence of the prothrombin needed for fibrin production. Fibrin once formed is known to provoke fibrinolysis by stimulating tissue The D-dimer fragments as degradation products can only originate from previously formed cross-linked fibrin. Evidence for cross-linking activity has been found with the demonstration of transglutaminase secretion through the anterior prostate in guinea pigs (11) and rats (12) . Transglutaminase or factor XIII activity, however, has not so far been detected in human semen (5, 13) , although our results suggest such an activity. The initiation of coagulation activation might be partly explained by the presence of prostate-specific antigen, which is believed to be a kallikrein-like serine protease in prostatic fluid, which cleaves the predominant seminal vesical protein (14) . It is well known that kallikrein is one of the activators of the intrinsic pathway of the clotting cascade.
Moreover Minhas et al. (15) have reported the presence of platelet-activating factor-like activity in human spermatozoa. Platelet-activating factor is a potent phospholipid with a wide spectrum of biological activities (16) which might induce activation of coagulation. Moreover Sugkraroek et al. (17) discussed the role of different levels of cholesterol and phospholipids in sperm from fertile and interfertile men. The presence of coagulation factors in seminal plasma need no longer be considered a strange phenomenon since Laurell et al. (18) recently reported the presence of very high concentrations (220 mg/1) of protein C inhibitor with a relative molecular mass of M T = 57 000 in seminal plasma. These concentrations are very high as compared with 5.3 mg/1 in blood plasma. They demonstrated the local production of protein C inhibitor in the male sex glands and the secretory origin in the seminal vesicles. Significantly lower values for D-dimer and D-dimer/thrombin-antithrombin III ratios were found in all groups of patients with infertility or after vasectomy in comparison with the control group. The D-dimer/thrombin-antithrombin III ratio can be seen as an indicator of the balance between fibrinolysis and coagulation. The decreased D-dimer/thrombin-antithrombin III ratio in both infertile and vasectomized patients suggests a disturbance of that balance, caused either by a shift towards coagulation activation, or to a reduction of fibrinolysis, or to both, and it is independent of the number of spermatozoa previously present. The D-dimer/thrombin-antithrombin III ratio is reduced in the infertile group as well as in the postvasectomy group, in whom no spermatozoa are present.
Groups I and IV show rather high thrombin-antithrombin III values with moderate D-dimer values, possibly indicating a retardation of the liquefaction of the coagulum, which might reduce the motility of the spermatozoa. This confirms a suggestion of Mandal et al. (3, 19) that there is a possible relationship between the coagulum liquefication properties of human ejaculates and the semen quality and that there is an association between subfertility and/or coagulum formation after ejaculation.
Furthermore, the similarity between the D-dimer/ thrombin-antithrombin III ratios in involuntary childless patients and in the postvasectomy patients is remarkable. The present results are an encouragement for further studies in this field, and they draw attention to coagulation and fibrinolysis markers in the evaluation of patients with fertility problems.
